Abstract
A 13-year-old female with a novel THRB gene mutation (c.1033G>T, p.G345C) presented with 3- to 6-fold higher serum iodothyronine levels and more severe clinical manifestation than 2 other family members carrying the same mutation. The leukocytes of the proband expressed both wild-type and mutant THRB mRNAs, excluding the possibility of a partial deletion of the allele not carrying the mutation. The proband's fibroblasts showed reduced responsiveness to triiodothyronine compared with those of another affected family member. The more severe clinical and biochemical phenotype suggest a modifier-mediated worsening of the resistance to thyroid hormone.
| Original language | English |
|---|---|
| Pages (from-to) | 1518-1520 |
| Number of pages | 3 |
| Journal | Thyroid |
| Volume | 29 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 10-2019 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Endocrinology